Literature DB >> 18845704

Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil.

Marie-Pierre St-Onge1, Aubrey Bosarge, Laura Lee T Goree, Betty Darnell.   

Abstract

OBJECTIVE: Medium chain triglyceride (MCT) consumption may have a beneficial impact on weight management, however, some studies point to a negative impact of MCT oil consumption on cardiovascular disease risk. This study examined the effects of MCT oil consumption, as part of a weight loss diet, on metabolic risk profile compared to olive oil.
DESIGN: Thirty-one men and women, age 19-50 y and body mass index 27-33 kg/m(2), completed this randomized, controlled, 16-week weight loss program. Oils were consumed at a level of approximately 12% of the subjects' prescribed energy intakes in the form of muffins and liquid oil.
RESULTS: After controlling for body weight, there was a significant effect of time on fasting serum glucose (P = 0.0177) and total cholesterol (P = 0.0386) concentrations, and on diastolic blood pressure (P = 0.0413), with reductions in these variables occurring over time; there was no time-by-diet interaction for any of the parameters studied. Two of the 3 subjects in the MCT oil group with evidence of the metabolic syndrome at baseline did not have metabolic syndrome at endpoint. In the olive oil group, 6 subjects had the metabolic syndrome at baseline; 2 subjects no longer had metabolic syndrome at endpoint, 1 person developed metabolic syndrome, and 4 subjects did not have any change in their metabolic syndrome status.
CONCLUSIONS: Our results suggest that MCT oil can be incorporated into a weight loss program without fear of adversely affecting metabolic risk factors. Distinction should be made regarding chain length when it comes to discussing the effects of saturated fats on metabolic risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845704      PMCID: PMC2874191          DOI: 10.1080/07315724.2008.10719737

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  28 in total

1.  Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects.

Authors:  L Asakura; A M Lottenberg; M Q Neves; V S Nunes; J C Rocha; M Passarelli; E R Nakandakare; E C Quintão
Journal:  Am J Clin Nutr       Date:  2000-03       Impact factor: 7.045

2.  Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee.

Authors:  Alice H Lichtenstein; Lawrence J Appel; Michael Brands; Mercedes Carnethon; Stephen Daniels; Harold A Franch; Barry Franklin; Penny Kris-Etherton; William S Harris; Barbara Howard; Njeri Karanja; Michael Lefevre; Lawrence Rudel; Frank Sacks; Linda Van Horn; Mary Winston; Judith Wylie-Rosett
Journal:  Circulation       Date:  2006-06-19       Impact factor: 29.690

3.  High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations.

Authors:  P M Kris-Etherton; T A Pearson; Y Wan; R L Hargrove; K Moriarty; V Fishell; T D Etherton
Journal:  Am J Clin Nutr       Date:  1999-12       Impact factor: 7.045

4.  Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women.

Authors:  F B Hu; M J Stampfer; J E Manson; A Ascherio; G A Colditz; F E Speizer; C H Hennekens; W C Willett
Journal:  Am J Clin Nutr       Date:  1999-12       Impact factor: 7.045

5.  Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters.

Authors:  P J Jones; M Raeini-Sarjaz; F Y Ntanios; C A Vanstone; J Y Feng; W E Parsons
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

6.  Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides.

Authors:  J O Hill; J C Peters; L L Swift; D Yang; T Sharp; N Abumrad; H L Greene
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

7.  Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides.

Authors:  L Scalfi; A Coltorti; F Contaldo
Journal:  Am J Clin Nutr       Date:  1991-05       Impact factor: 7.045

8.  The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men.

Authors:  P M Kris-Etherton; J Derr; D C Mitchell; V A Mustad; M E Russell; E T McDonnell; D Salabsky; T A Pearson
Journal:  Metabolism       Date:  1993-01       Impact factor: 8.694

9.  Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglycerides.

Authors:  L L Swift; J O Hill; J C Peters; H L Greene
Journal:  Am J Clin Nutr       Date:  1992-11       Impact factor: 7.045

10.  Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil.

Authors:  Marie-Pierre St-Onge; Aubrey Bosarge
Journal:  Am J Clin Nutr       Date:  2008-03       Impact factor: 7.045

View more
  16 in total

1.  High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.

Authors:  Adriana Lelis Carvalho; Victoria E DeMambro; Anyonya R Guntur; Phuong Le; Kenichi Nagano; Roland Baron; Francisco José Albuquerque de Paula; Katherine J Motyl
Journal:  J Cell Physiol       Date:  2017-08-04       Impact factor: 6.384

2.  Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors.

Authors:  Raghu R V Malapaka; Sokkean Khoo; Jifeng Zhang; Jang H Choi; X Edward Zhou; Yong Xu; Yinhan Gong; Jun Li; Eu-Leong Yong; Michael J Chalmers; Lin Chang; James H Resau; Patrick R Griffin; Y Eugene Chen; H Eric Xu
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

3.  Monounsaturated Fat vs Saturated Fat: Effects on Cardio-Metabolic Health and Obesity.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Mo Med       Date:  2022 Jan-Feb

4.  Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice.

Authors:  Shanshan Geng; Weiwei Zhu; Chunfeng Xie; Xiaoting Li; Jieshu Wu; Zhaofeng Liang; Wei Xie; Jianyun Zhu; Cong Huang; Mingming Zhu; Rui Wu; Caiyun Zhong
Journal:  Eur J Nutr       Date:  2015-04-25       Impact factor: 5.614

5.  Dietary Caprylic Acid (C8:0) Does Not Increase Plasma Acylated Ghrelin but Decreases Plasma Unacylated Ghrelin in the Rat.

Authors:  Fanny Lemarié; Erwan Beauchamp; Stéphanie Dayot; Cécile Duby; Philippe Legrand; Vincent Rioux
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

6.  An Increased Dietary Supply of Medium-Chain Fatty Acids during Early Weaning in Rodents Prevents Excessive Fat Accumulation in Adulthood.

Authors:  Bert J M van de Heijning; Annemarie Oosting; Diane Kegler; Eline M van der Beek
Journal:  Nutrients       Date:  2017-06-20       Impact factor: 5.717

Review 7.  Parenteral Nutrition and Lipids.

Authors:  Maitreyi Raman; Abdulelah Almutairdi; Leanne Mulesa; Cathy Alberda; Colleen Beattie; Leah Gramlich
Journal:  Nutrients       Date:  2017-04-14       Impact factor: 5.717

Review 8.  Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals.

Authors:  Sabri Ahmed Rial; Antony D Karelis; Karl-F Bergeron; Catherine Mounier
Journal:  Nutrients       Date:  2016-05-12       Impact factor: 5.717

Review 9.  Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Open Heart       Date:  2016-07-27

10.  Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study.

Authors:  Tohru Ohnuma; Aiko Toda; Ayako Kimoto; Yuto Takebayashi; Ryoko Higashiyama; Yuko Tagata; Masanobu Ito; Tsuneyoshi Ota; Nobuto Shibata; Heii Arai
Journal:  Clin Interv Aging       Date:  2016-01-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.